CUSIP: 55068A209
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / UNIT 11/30/2027
-
Total 13F shares
-
22,777,590
-
Share change
-
+20,664,690
-
Total reported value
-
$262,486,000
-
Price per share
-
$11.50
-
Number of holders
-
46
-
Value change
-
+$238,185,000
-
Number of buys
-
42
Quarterly Holders Quick Answers
What is CUSIP 55068A209?
CUSIP 55068A209 identifies LUXAU - LUX HEALTH TECH ACQUISITION - UNIT 11/30/2027 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 55068A209:
Institutional Holders of LUX HEALTH TECH ACQUISITION - UNIT 11/30/2027 (LUXAU) as of Q4 2020
As of 31 Dec 2020,
LUX HEALTH TECH ACQUISITION - UNIT 11/30/2027 (LUXAU) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,777,590 shares.
The largest 10 holders included
D1 Capital Partners L.P., MANUFACTURERS LIFE INSURANCE COMPANY, THE, Wolfswood Holdings, LLC, Balyasny Asset Management LLC, Empyrean Capital Partners, LP, BlueCrest Capital Management Ltd, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, MYDA Advisors LLC, BBR PARTNERS, LLC, and Senator Investment Group LP.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.